| 1 |
35247917 | Diaminobutoxy-substituted Isoflavonoid (DBI-1) Enhances the Therapeutic Efficacy of GLUT1 Inhibitor BAY-876 by Modulating Metabolic Pathways in Colon Cancer Cells. | 2022 May 4 |
2 |
| 2 |
34869036 | A Novel Microcrystalline BAY-876 Formulation Achieves Long-Acting Antitumor Activity Against Aerobic Glycolysis and Proliferation of Hepatocellular Carcinoma. | 2021 |
1 |
| 3 |
34906161 | TRIM38 triggers the uniquitination and degradation of glucose transporter type 1 (GLUT1) to restrict tumor progression in bladder cancer. | 2021 Dec 14 |
1 |
| 4 |
32826891 | GLUT1 inhibition blocks growth of RB1-positive triple negative breast cancer. | 2020 Aug 21 |
1 |
| 5 |
30861255 | Glucose transporter 1 regulates the proliferation and cisplatin sensitivity of esophageal cancer. | 2019 May |
1 |
| 6 |
30602670 | Ovarian Cancer Relies on Glucose Transporter 1 to Fuel Glycolysis and Growth: Anti-Tumor Activity of BAY-876. | 2018 Dec 31 |
5 |
| 7 |
27552707 | Identification and Optimization of the First Highly Selective GLUT1 Inhibitor BAY-876. | 2016 Oct 19 |
1 |